PGA
IDNA icon

Portland Global Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Portland Global Advisors’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.03M Buy
104,133
+1,129
+1% +$32.8K 0.32% 53
2025
Q4 		$2.7M Sell
103,004
-3
-0% -$77 0.29% 54
2025
Q3 		$2.43M Buy
103,007
+684
+0.7% +$15.1K 0.27% 53
2025
Q2 		$2.1M Buy
+102,323
New +$2.06M 0.25% 56

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

Portland Global Advisors's IDNA Position: Q1 2026 in Review

Portland Global Advisors increased its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 1.1% in Q1 2026, buying an estimated $32.8K and bringing the position to 104,133 shares worth $3.03M. The position accounts for 0.32% of the portfolio, ranked #53.

Portland Global Advisors first reported a position in IDNA in Q2 2025 and has held it in 4 quarters since. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

  • Portland Global Advisors held 104,133 shares of iShares Genomics Immunology and Healthcare ETF worth $3.03M as of Q1 2026.
  • Portland Global Advisors bought 1,129 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $32.8K.
  • iShares Genomics Immunology and Healthcare ETF made up 0.32% of Portland Global Advisors's portfolio in Q1 2026, its #53 holding.
  • Portland Global Advisors first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2025 and has held it in 4 quarters since.
  • 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Portland Global Advisors's 13F filing for Q1 2026, filed 11 May 2026.